Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rianne van der Linden"'
Autor:
Marcelo Sobral-Leite, Koen Van de Vijver, Magali Michaut, Rianne van der Linden, Gerrit K.J. Hooijer, Hugo M. Horlings, Tesa M. Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, Annuska M Glas, Diederik Wehkamp, Lorenza Mittempergher, Kelly Kersten, Ashley Cimino-Mathews, Dennis Peters, Erik Hooijberg, Annegien Broeks, Marc J. van de Vijver, Rene Bernards, Irene L. Andrulis, Marleen Kok, Karin E. de Visser, Marjanka K. Schmidt
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
To better understand the expression pattern of programmed death-ligand 1 (PD-L1) expression in different breast cancer types, we characterized PD-L1 expression in tumor and tumor-infiltrating immune cells, in relation to mutation rate, BRCA1-like sta
Externí odkaz:
https://doaj.org/article/f0b6f6923ae04f0aaadc16be5fe9261c
Autor:
Mathilde M, Almekinders, Tycho, Bismeijer, Tapsi, Kumar, Fei, Yang, Bram, Thijssen, Rianne, van der Linden, Charlotte, van Rooijen, Shiva, Vonk, Baohua, Sun, Edwin R, Parra Cuentas, Ignacio I, Wistuba, Savitri, Krishnamurthy, Lindy L, Visser, Iris M, Seignette, Ingrid, Hofland, Joyce, Sanders, Annegien, Broeks, Jason K, Love, Brian, Menegaz, Lodewyk, Wessels, Alastair M, Thompson, Karin E, de Visser, Erik, Hooijberg, Esther, Lips, Andrew, Futreal, Jelle, Wesseling
Publikováno v:
British journal of cancer. 127(7)
Ductal carcinoma in situ (DCIS) is treated to prevent subsequent ipsilateral invasive breast cancer (iIBC). However, many DCIS lesions will never become invasive. To prevent overtreatment, we need to distinguish harmless from potentially hazardous DC
Autor:
Jan de Boer, Charlotte L. Zuur, Annegien Broeks, Joris B. W. Elbers, Erik Hooijberg, Stefan M. Willems, Katherine Tan, Ekaterina S. Jordanova, Andries M. Bergman, Renee X. de Menezes, Bianca Cioni, Rianne van der Linden
Publikováno v:
Head & Neck
Head and Neck, 41(2), 463-478. Wiley Subscription Services, Inc., A Wiley Company Hoboken
Cioni, B, Jordanova, E S, Hooijberg, E, van der Linden, R, de Menezes, R X, Tan, K, Willems, S, Elbers, J B W, Broeks, A, Bergman, A M, Zuur, C L & de Boer, J P 2019, ' HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer ', Head and Neck, vol. 41, no. 2, pp. 463-478 . https://doi.org/10.1002/hed.25442
Head and Neck, 41(2), 463-478. Wiley Subscription Services, Inc., A Wiley Company Hoboken
Cioni, B, Jordanova, E S, Hooijberg, E, van der Linden, R, de Menezes, R X, Tan, K, Willems, S, Elbers, J B W, Broeks, A, Bergman, A M, Zuur, C L & de Boer, J P 2019, ' HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer ', Head and Neck, vol. 41, no. 2, pp. 463-478 . https://doi.org/10.1002/hed.25442
Background Human papillomavirus (HPV)‐positive oropharyngeal squamous cell carcinoma (OPSCC) is a highly immunogenic tumor and differences in tumor microenvironment might contribute to the improved survival of HPV‐positive OPSCC patient. Methods
Autor:
Erik Hooijberg, Anna Marie Mulligan, Diederik Wehkamp, Tesa M. Severson, René Bernards, Ashley Cimino-Mathews, Karin E. de Visser, Gerrit K. J. Hooijer, Marc J. van de Vijver, Hugo M. Horlings, Marcelo Sobral-Leite, Koen Van de Vijver, Marjanka K. Schmidt, Nayana Weerasooriya, Annegien Broeks, Lorenza Mittempergher, Annuska M. Glas, Dennis Peters, Magali Michaut, Kelly Kersten, Marleen Kok, Rianne van der Linden, Joyce Sanders, Irene L. Andrulis
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Oncoimmunology, 7(12):e1509820. Landes Bioscience
Oncoimmunology, 7(12):e1509820. Landes Bioscience
To better understand the expression pattern of programmed death-ligand 1 (PD-L1) expression in different breast cancer types, we characterized PD-L1 expression in tumor and tumor-infiltrating immune cells, in relation to mutation rate, BRCA1-like sta
Autor:
Yvo M. Smulders, Lars F.H. Theyse, Rianne van der Linden, Hans W.M. Niessen, Ilse P.A. Zethof, Robert Kleemann, Wessel W. Fuijkschot, Paul A.J. Krijnen, Martine C. Morrison
Publikováno v:
ATHEROSCLEROSIS
Atherosclerosis, 255, 164-170. Elsevier Ireland Ltd
Atherosclerosis, 255, 164-170
Fuijkschot, W W, Morrison, M C, van der Linden, R, Krijnen, P A J, Zethof, I P A, Theyse, L F H, Kleemann, R, Niessen, H W M & Smulders, Y M 2016, ' Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE-/-mice ', Atherosclerosis, vol. 255, pp. 164-170 . https://doi.org/10.1016/j.atherosclerosis.2016.07.909
Atherosclerosis, 255, 164-170. Elsevier Ireland Ltd
Atherosclerosis, 255, 164-170
Fuijkschot, W W, Morrison, M C, van der Linden, R, Krijnen, P A J, Zethof, I P A, Theyse, L F H, Kleemann, R, Niessen, H W M & Smulders, Y M 2016, ' Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE-/-mice ', Atherosclerosis, vol. 255, pp. 164-170 . https://doi.org/10.1016/j.atherosclerosis.2016.07.909
BACKGROUND AND AIMS: Observational studies show a peak incidence of cardiovascular events after major surgery. For example, the risk of myocardial infarction increases 25-fold early after hip replacement. The acuteness of this increased risk suggests
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3158524617f3a8fd3eb6472129da24bc
https://researchonline.rvc.ac.uk/id/eprint/10577/1/10577.pdf
https://researchonline.rvc.ac.uk/id/eprint/10577/1/10577.pdf
Autor:
Petra Kristel, Esther H. Lips, Annegien Broeks, Jelle Wesseling, Karin E. de Visser, Bram Thijssen, Erik Hooijberg, Rianne van der Linden, Mathilde M. Almekinders, Lindy L. Visser
Publikováno v:
Cancer Research. 78:3137-3137
Introduction Since the introduction of population-based mammographic screening, the incidence of ductal carcinoma in situ (DCIS) increased manifold. DCIS lesions are non-obligate precursors to invasive breast cancer, because only a minority of DCIS p
Autor:
Rianne van der Linden, Joyce Sanders, Karin E. de Visser, Philip C. Schouten, Annegien Broeks, René Bernards, Ashley Cimino-Mathews, Lodewyk F. A. Wessels, Dennis Peters, Marc J. van de Vijver, Erik Hooijberg, Nayana Weerasooriya, Anna Marie Mulligan, Marjanka K. Schmidt, Magali Michaut, Koen Van de Vijver, Tesa M. Severson, Kelly Kersten, Sabine C. Linn, Irene L. Andrulis, Marleen Kok, Gerrit K. J. Hooijer, Hugo M. Horlings, Marcelo Sobral-Leite
Publikováno v:
Cancer Research. 77:575-575
Background: PD-1 blockade has emerged as an effective treatment for a subset of cancer patients. Studies have shown that PD-L1 expression is associated with likelihood of response to PD-1 blockade. In order to select the right breast cancer patient f